Saima Aslam is an Infectious Disease physician affiliated with UC San Diego Health System. OpenAlex indexes 205 publications with 6,646 citations (h-index 42); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Efficacy Comparison of Itraconazole Pulse Therapy and Terbinafine Therapy in Treatment of Tinea Capitis in Children.
Sponsor: Muhammad Aamir Latif
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
87%Glycopeptide Antibacterial30.6%Vancomycin Hcl100%Part D≥11 patientsCephalosporin Antibacterial13%Cefpodoxime Proxetil100%Part D<11 patients+ 4 more classes in this area
Sensory organs
13%Fluoroquinolone Antibacterial13%Ciprofloxacin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2010–2025 per NIH RePORTER. The latest:
- Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
University of California, San Diego
FY2025$317,863R01DK134726 - Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
University of California, San Diego
FY2024$332,372R01DK134726 - Anti-Biofilm Strategies for Treating Infected Hemodialysis Catheters
University of California, San Diego
FY2013$149,278K23DK078828
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Lowy, MD
UC San Diego Health System
Roger Spragg, MD
UC San Diego Health System
Rafael Bejar, MD, PhD
UC San Diego Health System
Zea Borok, MD
UC San Diego Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”